Elevai Labs, Inc. announced that they have signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience?s mitochondrial research with ELEVAI?s PREx? (Precision Regenerative Exosome Technology?) to potentially develop topical skincare formulations that combine mitochondrial biology with Elevai?s human umbilical mesenchymal stem cell derived exosomes. Elevai currently markets its proprietary ELEVAI E-Series which are peri-procedure topical exosome skincare products.

Yuva Biosciences utilizes mitochondrial science to address signs of aging of hair, scalp, and skin. Yuva Biosciences has built a platform that includes a leading-edge AI model to rapidly screen huge numbers of natural compounds for their effectiveness in improving mitochondrial health.